FDA's approval of new mRNA vaccine does not necessarily signal the government's embrace of the technology, experts say
The U.S. Food and Drug Administration approved an mRNA-based vaccine for influenza. Live Science asked experts what that means for the future of mRNA vaccines in the U.S.
We haven't written up this one. Live Science has the full story — the link below goes straight to it.